If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 231 - 240 of 279
An Open-Label, Phase 2b, Global Multi-Center Cohort Trial to Assess the Safety and Efficacy of Zipalertinib in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Exon 20 Insertions and Uncommon/Single or Compound Epidermal G
Objective
Study of of Zipalertinib in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Protocol No
TAIHO-TAS6417-201
Categories
A Multisite, Phase II Study of Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
Objective
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory MM
Protocol No
IIT-DHAKAL-IMPEDE-SGZ-12356
Categories
A Multisite, Phase II Study of Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone (VICD) Induction in Transplant-Eligible Multiple Myeloma Patients with Renal Insufficiency
Objective
Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple
Protocol No
IIT-DHAKAL-VICD-MM
Categories
A Randomized Phase II Trial of Consolidation Therapy Following CD19 CAR T-Cell Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Grade IIIB Follicular Lymphoma
Objective
To find out if this approach is better or worse than the usual approach for DLBCL patients receiving CAR T-cell therapy. The usual approach for Relapsed/Refractory DLBCL patients is follow-up visits with no further therapy.
Protocol No
SWOG-S2114
Categories
Latina Breast Cancer Survivors' Experiences with Cancer-Related Cognitive Impairment
Objective
Latina Breast Cancer Survivors and Cognition
Protocol No
IIT-MORELLI-LATINAS-CRCI
Categories
Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery
Objective
Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery
Protocol No
IIT-ZENGA-SSI-OCR
Categories
Exogenous Tuning of Neural Oscillations as a Mode of Treatment in Post-stroke Subacute Aphasia
Objective
Transcranial Alternating Current Stimulation (tACS) in Subacute Aphasia
Protocol No
NEURO-MCW-TACS-SUBACUTEAPHASIA
Categories
Evaluation of a Simple-Prep Controlled Embolic (GPX Trial)
Objective
Evaluation of a Simple-Prep Controlled Embolic (GPX)
Protocol No
VIR-FLUIDX-GPX
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Objective
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Protocol No
NRG-BN003
Categories
A Randomized Phase III Trial of Olanzapine Versus Megestrol Acetate for Cancer-Associated Anorexia
Objective
Olanzapine vs Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
Protocol No
ALLIANCE-A222004-ANOREXIA
Categories
Cancer,
Cervix,
Lip, Oral Cavity and Pharynx,
Endocrine Cancers,
Prostate and Urologic Cancers,
Other Skin,
Breast Cancers,
Other Respiratory,
Gastrointestinal Cancers,
Uterine,
Thoracic Cancers,
Gynecologic Cancers,
Sarcoma,
Eye/Orbital Cancers,
Skin Cancers,
Larynx,
Head and Neck Cancers,
Brain and Spine Cancers